We have received funding by means of sponsorship from multiple pharmaceutical companies and MedTech industries to support the delivery of our national conference. The sponsoring companies are AgaMatrix Europe Limited, A. Menarini Farmaceutica Internazionale SRL, Glooko and mylife Diabetes Care.
Our sponsors have had no editorial input or control over the agenda, content development or choice of speakers.
AgaMatrix Europe Limited, based in Oxfordshire, is a specialised diabetes monitoring company. Three core values drive our product development: Accuracy, features and value. ALLYbgk is our latest innovation in blood glucose monitoring, providing both glucose and β-ketone testing to the NHS for exceptional value for money. ALLYcgm is our continuous glucose monitor which provides the accuracy you need, the features you want and better value to the patient and the NHS. Diabetes monitoring is our purpose, and our people are passionate about making a difference to the lives of those managing this condition. Come and visit our stand to find out more about our recent listings on Part IX of the Drug Tariff for ALLYbgk and ALLYcgm.
Learn more here: https://allycgm.co.uk/ and https://agamatrix.co.uk/
A. Menarini Farmaceutica Internazionale SRL is the UK subsidiary of the Menarini group which is present in 140 countries worldwide, headquartered in Florence. We work to partner with the NHS, identifying opportunities where our products can make a real difference to patients’ lives in both primary and secondary care. Menarini Group has been supporting people living with diabetes for over 30 years.
For more information please visit: www.menarinipro.co.uk
Glooko is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care
continuum. Glooko is uniquely positioned to be the enterprise partner of choice for
healthcare providers seeking to reduce glycemic risk, improve safety, and support
overburdened clinical teams with coordinated expertise across both outpatient and
inpatient care settings.
Learn more here: https://glooko.com/
mylife Diabetes Care is dedicated to simplifying diabetes management through innovative, intuitive technology. At the heart of our offering is myLoop, our hybrid closed-loop (HCL) therapy designed to reduce the everyday burden of diabetes management and give people greater freedom and confidence.
Coming to myLoop is CamAPS Liberty, a fully closed-loop feature within CamDiab’s CamAPS FX app, offering greater automation and flexibility when users want to ease the burden of routine meal-related decisions.
Learn more here: Home – mylife Diabetescare – United Kingdom